Table I.
Group | Body weight, g | Final tumor volume, cm3 | Final tumor weight, g | Inhibition rate, % (volume/weight) | |
---|---|---|---|---|---|
| |||||
Pre-treatment | Post-treatment | ||||
Negative control | 21.85±0.99 | 20.67±1.29 | 2.01±0.52 | 2.84±0.39 | |
CTX | 21.46±0.63 | 31.49±2.26 | 0.53±0.12 | 0.9±0.28 | 73.63/72.18a |
50 mg/kg | 21.37±1.11 | 30.75±2.39 | 1.65±0.43 | 2.11±0.61 | 17.91/25.70b |
100 mg/kg | 20.11±0.68 | 28.68±3.12 | 0.69±0.21 | 1.00±0.38 | 65.67/64.79a |
P<0.0001;
P<0.001.
S03-EA, ethyl acetate extract; CTX, cyclophosphamide.